Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer

Molecular therapeutics for treating epidermal growth factor receptor-(EGFR-) expressing cancers are a specific method for treating cancers compared to general cell loss with standard cytotoxic therapeutics. However, the finding that resistance to such therapy is common in clinical trials now dampens...

Descripción completa

Detalles Bibliográficos
Autores principales: Elferink, Lisa A., Resto, Vicente A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135278/
https://www.ncbi.nlm.nih.gov/pubmed/21776391
http://dx.doi.org/10.1155/2011/982879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135278/
https://www.ncbi.nlm.nih.gov/pubmed/21776391
http://dx.doi.org/10.1155/2011/982879

Ejemplares similares